BMP2 and renal cell carcinoma: A recent study by Mitsui et al. revealed that impaired regulation of Bmp-2 via epigenetic pathways was associated with RCC pathogenesis and confirms the usefulness of BMP-2 as a molecular marker for designing improved diagnostic and therapeutic strategies for RCC [103].